Sökning: onr:"swepub:oai:gup.ub.gu.se/99128" >
The mission is remi...
The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression.
-
- Sobocki, P (författare)
- Karolinska Institutet
-
- Ekman, M (författare)
- Stockholm Health Economics
-
- Ågren, Hans, 1945 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry,Karolinska University Hospital
-
visa fler...
-
- Runeson, B (författare)
- Karolinska Institutet
-
- Jönsson, B. (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
visa färre...
-
(creator_code:org_t)
- 2008-10-09
- 2006
- Engelska.
-
Ingår i: International journal of clinical practice. - : Hindawi Limited. - 1368-5031 .- 1742-1241. ; 60:7, s. 791-8
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
https://research.hhs...
-
visa färre...
Abstract
Ämnesord
Stäng
- The aim of the present study was to determine the magnitude of the impact of treating depression to full remission on cost and health-related quality of life. In a naturalistic longitudinal survey recordings of resource use and quality of life were carried out among depressed patients treated with antidepressant therapy in 56 Swedish primary care clinics. We found that a total of 52% of the patients achieved full remission during the study period. Remitting patients had, on average, three outpatient visits less than non-remitting patients (p < 0.01), 22 fewer sick leave days (p = 0.01), which translated into a significantly lower total cost (Euro 2700) compared with non-remitting patients (p < 0.01). Health-related quality-of-life scores improved by 40% for remitting patients when compared with non-remitting ones (p < 0.01). We conclude that remission has a substantial health economic impact on patients treated for depression, which further strengthens the importance of aiming for full remission in the treatment of depression.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Psykiatri (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Psychiatry (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)
Nyckelord
- Adult
- Ambulatory Care
- economics
- statistics & numerical data
- Antidepressive Agents
- economics
- therapeutic use
- Cost of Illness
- Cost-Benefit Analysis
- Depressive Disorder
- drug therapy
- economics
- Female
- Humans
- Longitudinal Studies
- Male
- Quality of Life
- Remission Induction
- Sick Leave
- economics
- statistics & numerical data
- Time Factors
- Treatment Outcome
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas